{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:09:07Z","timestamp":1793066947025,"version":"4.5.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ijbiomac.2024.130644","type":"journal-article","created":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T04:13:57Z","timestamp":1709871237000},"page":"130644","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"P1","title":["An allosteric mechanism for potent inhibition of SARS-CoV-2 main proteinase"],"prefix":"10.1016","volume":"265","author":[{"given":"Yunju","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Qiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuguang","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6557","key":"10.1016\/j.ijbiomac.2024.130644_bb0005","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1126\/science.abg5827","article-title":"Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2","volume":"373","author":"Drayman","year":"2021","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.130644_bb0010","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00109-21","article-title":"SARS-CoV-2 antiviral therapy","volume":"34","author":"Tao","year":"2021","journal-title":"Clin. Microbiol. Rev."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.130644_bb0015","doi-asserted-by":"crossref","first-page":"E91","DOI":"10.1016\/S2666-5247(21)00278-0","article-title":"The emergence of powerful oral anti-COVID-19 drugs in the post-vaccine era","volume":"3","author":"Fan","year":"2022","journal-title":"Lancet Microbe"},{"issue":"18","key":"10.1016\/j.ijbiomac.2024.130644_bb0020","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1111\/febs.12936","article-title":"From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design","volume":"281","author":"Hilgenfeld","year":"2014","journal-title":"FEBS J."},{"issue":"46","key":"10.1016\/j.ijbiomac.2024.130644_bb0025","doi-asserted-by":"crossref","first-page":"12997","DOI":"10.1073\/pnas.1601327113","article-title":"SARS-CoV 3CL protease cleaves its C-terminal autoprocessing site by novel subsite cooperativity","volume":"113","author":"Muramatsu","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.130644_bb0030","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41579-021-00630-8","article-title":"Structural biology of SARS-CoV-2 and implications for therapeutic development","volume":"19","author":"Yang","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"issue":"7811","key":"10.1016\/j.ijbiomac.2024.130644_bb0035","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of M(pro) from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2024.130644_bb0040","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.coviro.2021.06.004","article-title":"Progress and pitfalls of a year of drug repurposing screens against COVID-19","volume":"49","author":"Sourimant","year":"2021","journal-title":"Curr. Opin. Virol."},{"issue":"7798","key":"10.1016\/j.ijbiomac.2024.130644_bb0045","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.130644_bb0050","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.sbi.2005.10.004","article-title":"Structural insights into SARS coronavirus proteins","volume":"15","author":"Bartlam","year":"2005","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"6489","key":"10.1016\/j.ijbiomac.2024.130644_bb0055","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved alpha-ketoamide inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science"},{"issue":"23","key":"10.1016\/j.ijbiomac.2024.130644_bb0060","doi-asserted-by":"crossref","first-page":"13190","DOI":"10.1073\/pnas.1835675100","article-title":"The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor","volume":"100","author":"Yang","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.130644_bb0065","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1128\/JVI.02114-07","article-title":"Structures of two coronavirus main proteases: implications for substrate binding and antiviral drug design","volume":"82","author":"Xue","year":"2008","journal-title":"J. Virol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.130644_bb0070","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1021\/acs.jproteome.0c00683","article-title":"Theoretical insights into the anti-SARS-CoV-2 activity of chloroquine and its analogs and in silico screening of Main protease inhibitors","volume":"19","author":"Achutha","year":"2020","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.ijbiomac.2024.130644_bb0075","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1021\/jacsau.3c00185","article-title":"Dynamical nonequilibrium molecular dynamics simulations identify allosteric sites and positions associated with drug resistance in the SARS-CoV-2 Main protease","volume":"3","author":"Chan","year":"2023","journal-title":"Jacs Au"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.130644_bb0080","doi-asserted-by":"crossref","first-page":"2000246","DOI":"10.1002\/pmic.202000246","article-title":"N-Terminomics for the identification of in vitro substrates and cleavage site specificity of the SARS-CoV-2 Main protease","volume":"21","author":"Koudelka","year":"2021","journal-title":"Proteomics"},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.130644_bb0085","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.chembiol.2008.04.011","article-title":"A structural view of the inactivation of the SARS coronavirus main proteinase by benzotriazole esters","volume":"15","author":"Verschueren","year":"2008","journal-title":"Chem. Biol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.130644_bb0090","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.3390\/molecules26102917","article-title":"Targeting multiple signal transduction pathways of SARS-CoV-2: approaches to COVID-19 therapeutic candidates","volume":"26","author":"Fakhri","year":"2021","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.130644_bb0095","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3390\/v13020173","article-title":"Development of a cell-based luciferase complementation assay for identification of SARS-CoV-2 3CL(pro) inhibitors","volume":"13","author":"Rawson","year":"2021","journal-title":"Viruses"},{"issue":"6536","key":"10.1016\/j.ijbiomac.2024.130644_bb0100","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1126\/science.abf1611","article-title":"SARS-CoV-2 M(pro) inhibitors with antiviral activity in a transgenic mouse model","volume":"371","author":"Qiao","year":"2021","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.130644_bb0105","first-page":"2000028","article-title":"Rapid identification of potential inhibitors of SARS-CoV-2 Main protease by deep docking of 1.3 billion compounds, Mol","volume":"39","author":"Ton","year":"2020","journal-title":"Inform"},{"issue":"14","key":"10.1016\/j.ijbiomac.2024.130644_bb0110","doi-asserted-by":"crossref","first-page":"6405","DOI":"10.1021\/acs.jmedchem.8b01749","article-title":"Allosteric modulator discovery: from serendipity to structure-based design","volume":"62","author":"Lu","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.130644_bb0115","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev-pharmtox-010611-134525","article-title":"Drugs for allosteric sites on receptors","volume":"54","author":"Wenthur","year":"2014","journal-title":"Annu. Rev. Pharmacol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.130644_bb0120","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jmb.2016.01.029","article-title":"CryptoSite: expanding the Druggable proteome by characterization and prediction of cryptic binding sites","volume":"428","author":"Cimermancic","year":"2016","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2024.130644_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.sbi.2017.10.002","article-title":"Structure-based prediction of protein allostery","volume":"50","author":"Greener","year":"2018","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"6542","key":"10.1016\/j.ijbiomac.2024.130644_bb0130","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1126\/science.abf7945","article-title":"X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease","volume":"372","author":"Gunther","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2024.130644_bb0135","series-title":"The PyMOL Molecular Graphics System","author":"DeLano","year":"2002"},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.130644_bb0140","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1002\/prot.22711","article-title":"Improved side-chain torsion potentials for the Amber ff99SB protein force field","volume":"78","author":"Lindorff-Larsen","year":"2010","journal-title":"Proteins: Struct., Funct., Bioinf."},{"issue":"16","key":"10.1016\/j.ijbiomac.2024.130644_bb0145","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/jcc.20290","article-title":"The Amber biomolecular simulation programs","volume":"26","author":"Case","year":"2005","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ijbiomac.2024.130644_bb0150","unstructured":"M.J.T. Frisch, G.W.; Schlegel, H.B.; Scuseria, G.E.; Robb, M.A.; Cheeseman, J.R.; Scalmani, G.; Barone, V.; Petersson, G.A.; Nakatsuji, H.; et al., Gaussian 09, Revision A02, Gaussian. Inc. Wallingford. CT 7 (2016)."},{"issue":"16","key":"10.1016\/j.ijbiomac.2024.130644_bb0155","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: fast, flexible, and free","volume":"26","author":"Van Der Spoel","year":"2005","journal-title":"J. Comput. Chem."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.130644_bb0160","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J. Chem. Phys."},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.130644_bb0165","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","article-title":"LINCS: a linear constraint solver for molecular simulations","volume":"18","author":"Hess","year":"1997","journal-title":"J. Comput. Chem."},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.130644_bb0170","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: AnN\u00b7log(N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J. Chem. Phys."},{"issue":"19","key":"10.1016\/j.ijbiomac.2024.130644_bb0175","doi-asserted-by":"crossref","first-page":"8577","DOI":"10.1063\/1.470117","article-title":"A smooth particle mesh Ewald method","volume":"103","author":"Essmann","year":"1995","journal-title":"J. Chem. Phys."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.130644_bb0180","doi-asserted-by":"crossref","DOI":"10.1063\/1.2408420","article-title":"Canonical sampling through velocity rescaling","volume":"126","author":"Bussi","year":"2007","journal-title":"J. Chem. Phys."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.130644_bb0185","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1063\/1.448118","article-title":"Molecular-dynamics with coupling to an external Bath","volume":"81","author":"Berendsen","year":"1984","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ijbiomac.2024.130644_bb0190","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1023\/A:1008763014207","article-title":"Combined molecular mechanical and continuum solvent approach (MM-PBSA\/GBSA) to predict ligand binding","volume":"18","author":"Massova","year":"2000","journal-title":"Perspect. Drug Discov. Des."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.130644_bb0195","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1080\/1062936X.2015.1070200","article-title":"Combined molecular dynamics and continuum solvent approaches (MM-PBSA\/GBSA) to predict noscapinoid binding to gamma-tubulin dimer","volume":"26","author":"Suri","year":"2015","journal-title":"SAR QSAR Environ. Res."},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.130644_bb0200","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1021\/ct300418h","article-title":"MMPBSA.Py: An efficient program for end-state free energy calculations","volume":"8","author":"Miller","year":"2012","journal-title":"J. Chem. Theory Comput."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.130644_bb0205","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1080\/07391102.2015.1071281","article-title":"Influence of the R823W mutation on the interaction of the ANKS6-ANKS3: insights from molecular dynamics simulation and free energy analysis","volume":"34","author":"Kan","year":"2016","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"13","key":"10.1016\/j.ijbiomac.2024.130644_bb0210","doi-asserted-by":"crossref","first-page":"9202","DOI":"10.1039\/C5CP06276D","article-title":"Underlying mechanisms of cyclic peptide inhibitors interrupting the interaction of CK2alpha\/CK2beta: comparative molecular dynamics simulation studies","volume":"18","author":"Zhou","year":"2016","journal-title":"Phys. Chem. Chem. Phys."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.130644_bb0215","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/prot.340170408","article-title":"Essential dynamics of proteins","volume":"17","author":"Amadei","year":"1993","journal-title":"Proteins"},{"issue":"16","key":"10.1016\/j.ijbiomac.2024.130644_bb0220","doi-asserted-by":"crossref","first-page":"6620","DOI":"10.1073\/pnas.0810961106","article-title":"Dynamical networks in tRNA: protein complexes","volume":"106","author":"Sethi","year":"2009","journal-title":"P Natl Acad Sci USA"},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.130644_bb0225","doi-asserted-by":"crossref","first-page":"7821","DOI":"10.1073\/pnas.122653799","article-title":"Community structure in social and biological networks","volume":"99","author":"Girvan","year":"2002","journal-title":"P Natl Acad Sci USA"},{"issue":"22","key":"10.1016\/j.ijbiomac.2024.130644_bb0230","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1093\/bioinformatics\/bts546","article-title":"NetworkView: 3D display and analysis of protein center dot RNA interaction networks","volume":"28","author":"Eargle","year":"2012","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.130644_bb0235","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph. Model."},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.130644_bb0240","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s00894-020-04600-4","article-title":"Identification of saquinavir as a potent inhibitor of dimeric SARS-CoV2 main protease through MM\/GBSA","volume":"26","author":"Bello","year":"2020","journal-title":"J. Mol. Model."},{"issue":"19","key":"10.1016\/j.ijbiomac.2024.130644_bb0245","doi-asserted-by":"crossref","first-page":"9287","DOI":"10.1080\/07391102.2021.1927844","article-title":"Binding mode characterization of 13b in the monomeric and dimeric states of SARS-CoV-2 main protease using molecular dynamics simulations","volume":"40","author":"Kumari","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ijbiomac.2024.130644_bb0250","first-page":"1","article-title":"Theoretical insights into the binding interaction of Nirmatrelvir with SARS-CoV-2 Mpro mutants (C145A and C145S): MD simulations and binding free-energy calculation to understand drug resistance","author":"Purohit","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ijbiomac.2024.130644_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105381","article-title":"Allosteric inhibitors of the main protease of SARS-CoV-2","volume":"205","author":"Samrat","year":"2022","journal-title":"Antiviral Res."},{"issue":"23\u201324","key":"10.1016\/j.ijbiomac.2024.130644_bb0260","first-page":"2375","article-title":"The key-lock theory and the induced fit theory","volume":"33","author":"Koshland","year":"1994","journal-title":"Angew. Chem. Int. Edit."},{"key":"10.1016\/j.ijbiomac.2024.130644_bb0265","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.18249","article-title":"Allosteric activation of SENP1 by SUMO1 beta-grasp domain involves a dock-and-coalesce mechanism","volume":"5","author":"Guo","year":"2016","journal-title":"Elife"},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.130644_bb0270","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1021\/acs.jcim.5b00755","article-title":"Probing allosteric inhibition mechanisms of the Hsp70 chaperone proteins using molecular dynamics simulations and analysis of the residue interaction networks","volume":"56","author":"Stetz","year":"2016","journal-title":"J. Chem. Inf. Model."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.130644_bb0275","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.str.2014.11.009","article-title":"Two pathways mediate Interdomain allosteric regulation in Pin1","volume":"23","author":"Guo","year":"2015","journal-title":"Structure"},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.130644_bb0280","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.str.2009.06.008","article-title":"The origin of allosteric functional modulation: multiple pre-existing pathways","volume":"17","author":"del Sol","year":"2009","journal-title":"Structure"},{"issue":"20","key":"10.1016\/j.ijbiomac.2024.130644_bb0285","doi-asserted-by":"crossref","first-page":"6823","DOI":"10.3390\/molecules27206823","article-title":"Elucidation of binding features and dissociation pathways of inhibitors and modulators in SARS-CoV-2 Main protease by multiple molecular dynamics simulations","volume":"27","author":"Xu","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2024.130644_bb0290","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.2147\/DDDT.S370574","article-title":"Allosteric binding sites of the SARS-CoV-2 main protease: potential targets for broad-spectrum anti-coronavirus agents","volume":"16","author":"Alzyoud","year":"2022","journal-title":"Drug Des Dev Ther"},{"issue":"19","key":"10.1016\/j.ijbiomac.2024.130644_bb0295","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.2174\/138161209788682514","article-title":"Comprehensive assessment of ADMET risks in drug discovery","volume":"15","author":"Wang","year":"2009","journal-title":"Curr Pharm Design"},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.130644_bb0300","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/cpt.1435","article-title":"Clinical studies on drug-drug interactions involving metabolism and transport: methodology, pitfalls, and interpretation","volume":"105","author":"Tornio","year":"2019","journal-title":"Clin Pharmacol Ther"},{"issue":"7403","key":"10.1016\/j.ijbiomac.2024.130644_bb0305","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nature11159","article-title":"Large-scale prediction and testing of drug activity on side-effect targets","volume":"486","author":"Lounkine","year":"2012","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.130644_bb0310","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-38859-x","article-title":"Empowering drug off-target discovery with metabolic and structural analysis","volume":"14","author":"Chowdhury","year":"2023","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.130644_bb0315","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/s41587-021-00946-z","article-title":"Prediction of drug efficacy from transcriptional profiles with deep learning","volume":"39","author":"Zhu","year":"2021","journal-title":"Nat. Biotechnol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024014478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024014478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T11:21:57Z","timestamp":1758885717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813024014478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":63,"alternative-id":["S0141813024014478"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.130644","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An allosteric mechanism for potent inhibition of SARS-CoV-2 main proteinase","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.130644","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"130644"}}